Justin Meiklem

HEALTH CANADA GRANTS BIOHARVEST SCIENCES LICENSE FOR VINIA SALES IN CANADA

2023 /

Vancouver, British Columbia and Rehovot, Israel – October 10th, 2023, BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that VINIA®, its flagship nutraceutical product derived from red grape cells, has received its Canadian product license from Health Canada’s Natural and Non-Prescription Health Products Directorate. This Product License authorizes BioHarvest […]

HEALTH CANADA GRANTS BIOHARVEST SCIENCES LICENSE FOR VINIA SALES IN CANADA Read More »

Vinia

BIOHARVEST ANNOUNCES AUGUST 2023 U.S. VINIA SALES EXCEEDED USD $1MILLION

2023 /

Vancouver, British Columbia and Rehovot, Israel – September 6th, 2023 BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that US sales of its flagship product VINIA® in the month of August have crossed the USD 1Million per month line. This significant milestone marks a new inflection point in BioHarvest’s

BIOHARVEST ANNOUNCES AUGUST 2023 U.S. VINIA SALES EXCEEDED USD $1MILLION Read More »

BIOHARVEST SCIENCES REPORTS Q2 2023 RESULTS DEMONSTRATING CONTINUED GROWTH MOMENTUM

2023 /

Vancouver, British Columbia and Rehovot, Israel – August 30, 2023-  BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that it has released Q2 2023 results. Revenue of its flagship VINIA® product reached USD 2.75M, representing 228% growth compared to the same quarter of last year and 27% growth compared

BIOHARVEST SCIENCES REPORTS Q2 2023 RESULTS DEMONSTRATING CONTINUED GROWTH MOMENTUM Read More »

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER PRESENTATION SEPTEMBER 6, 2023, 2:30 PM ET

2023 /

VANCOUVER, CANADA, AND REHOVOT, ISRAEL, August 24, 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) announces that it is hosting the Q2 Performance Update Presentation on Wednesday, September 6, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by CEO Ilan Sobel. Mr. Sobel will discuss

BIOHARVEST SCIENCES TO HOST VIRTUAL SHAREHOLDER PRESENTATION SEPTEMBER 6, 2023, 2:30 PM ET Read More »

img

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES

2023 /

VANCOUVER, CANADA, and REHOVOT, ISRAEL, July 18 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”) previously announced on July 7, 2023. The Company has issued Notes in the aggregate principal amount of

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES Read More »

BioHarvest Sciences Chief Medical Officer to speak at Collision Conference in Toronto

2023 /

Dr. Brian Cornblatt will give the keynote address on the “HealthConf” Stage at Collision Vancouver, British Columbia, and Rehovot, Israel– (June 27, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) has been invited to one of the largest and fastest-growing technology conferences in North America. Its Chief Medical Officer,

BioHarvest Sciences Chief Medical Officer to speak at Collision Conference in Toronto Read More »